ERBB2 and breast cancer: In addition, patients in subgroup like diagnosis year in 2008–2020, less well-education, urban schemes, breast cancer with hormone receptor-positive, HER2-negative, stage T1 or N3, the increased risk for the elderly patients still be significant.